Stifel reiterates Salesforce stock Buy rating on revenue growth

Stifel maintained a Buy rating and $275 price target on Salesforce, citing accelerating net new annualized order value growth and expectations for subscription growth to improve in the second half. Salesforce generated 11.23% trailing-12-month revenue growth, a 77.28% gross margin, and a 25.81% six-month stock gain; Stifel expects it to reiterate its FY2030 $63B revenue target versus $43.94B in trailing revenue. Investor focus at Dreamforce and Analyst Day will be on a potential FY2028 growth outlook of at least 10%, plus AI monetization opportunities through Agentforce, Data360, Headless 360 and the Anthropic partnership.

Analysis

CRM is entering a classic expectation-risk event window: the valuation debate has shifted from margin durability to whether AI products can create enough incremental net-new ACV to sustain a durable re-acceleration. Management commentary on product adoption is insufficient; the market needs disclosed paid-seat conversion, consumption revenue, attach rates to Data Cloud, and evidence that AI pricing expands rather than cannibalizes existing Service and Sales Cloud spend. Without those KPIs, an ambitious long-range target is more likely to compress the multiple than extend it.

The near-term setup favors a “show-me” reaction over the next days to 1-3 months. CRM’s large installed base and direct sales distribution give it a monetization advantage versus point AI vendors, but enterprise buyers may initially treat copilots as budget reallocation rather than incremental software spend. That creates a second-order headwind for CRM’s ecosystem: implementation partners such as ACN and GLOB could see lower billable customization intensity if AI deployment is packaged more natively, while legacy customer-service software vendors face greater displacement risk.

The contrarian view is that consensus may be underestimating the operating leverage if Data Cloud becomes the system-of-record layer for AI workflows; incremental consumption revenue would carry attractive gross margin and require limited incremental sales capacity. Conversely, the downside is not primarily a revenue miss but a failure to establish a credible intermediate growth bridge, leaving the market unwilling to pay a premium for a distant margin-and-growth endpoint. Watch bookings/RPO growth, subscription growth guidance, and disclosed AI monetization at the next earnings release; a downgrade in any of these would falsify the re-acceleration thesis.

Key Decisions for Investors

• Do not chase CRM into its investor-event window; initiate or add only if management provides quantifiable paid AI/consumption metrics and the stock holds the post-event reaction for 2-3 sessions. Target a 6-12 month long only on evidence of accelerating bookings, with a stop/review trigger on a material reduction in next-year subscription-growth guidance.
• For existing CRM exposure, buy 1-3 month downside protection around the event via put spreads rather than outright puts; elevated expectations make a 8-12% disappointment move plausible, while a generic AI product demonstration may not justify a sustained upside rerating.
• Relative-value watch: long CRM versus short a basket of lower-scale customer-experience SaaS names only after CRM demonstrates measurable AI attach rates. The thesis is distribution-led consolidation of enterprise workflow budgets; avoid initiating without disclosed monetization data.
• Avoid treating APP and SMCI as read-through trades. Their inclusion is promotional rather than economically connected; CRM’s relevant confirmation comes from enterprise software spending, RPO/bookings trends, and cloud-consumption KPIs.